Flubendazole is a benzimidazole which has an anthelmintic activity against most nematode and other worms. Its action as anti-worms occurs by hindering the polymerization and preventing the reabsorption of glucose by hindering the parasite. This will lead to the elimination of intestinal worms.

 

Flubendazole is poorly absorbed from the gastrointestinal tract.

Flubendazole is excreted by feces during the following 3 days after the administration of 100 mg.

Plasma concentrations and renal excretion of  Flubendazole are negligible.    

 

VERMA is indicated for the following cases:

- Oxyurose.

- Ascariasis.

- Trichocephalosis.

- Ancylostomiasis.

 

Flubendazole is contraindicated in patients when with known hypersensitivity to the benzimidazole class of compounds.

 

Flubendazole is contraindicated in pregnancy. Caution should be exercised when Flubendazole is administered to a nursing women.

 

Digestive disorders: Diarrhea, nausea and  abdominal pain.

 

Adults: VERMA tablets may be chewed, swallowed or crushed and mixed with food. No specific procedures such as fasting or purging are required.

Oxyurose: Single dose of 100 mg to be repeated after 15-20 days if necessary. Ascariasis,Trichocephalosis and Ancylostomiasis: 100 mg morning and evening for 3 consecutive days .

High levels of cleanliness and hygiene must be maintained during therapy.  

 

In case of overdosage, symptomatic therapy e.g. (gastric lavage and activated charcoal) and general supportive measures are recommended.

 

VERMA -  Tablets: A pack of 6 tablets. Each tablet contains 100 mg Flubendazole.

 

Store VERMA -  Tablets at temperature between (15-30)°C.